Stay updated on Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy evaluation of dupilumab monotherapy compared to placebo treatment in adult participants with moderate-to-severe atopic dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:19.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of what eligibility criteria entail for clinical research participation.
    Difference
    34%
    Check dated 2024-05-22T21:29:18.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:43:48.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.